Transpacific TAVR Registry

Study overview

This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Collaborators and Investigators

Duk-Woo Park, MD,

Alan Ching Yuen Yeung, MD, PRINCIPAL_INVESTIGATOR, Stanford University

James D. Flaherty, MD, PRINCIPAL_INVESTIGATOR, Northwestern University

Study Record Dates

2036-12-31